Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patients
Gatell, Josep M, Morales-Ramirez, Javier O, Hagins, Debbie P, Thompson, Melanie, Keikawus, Arasteh, Hoffmann, Christian, Rugina, Sorin, Osiyemi, Olayemi, Escoriu, Simona, Dretler, Robin, Harvey, CharlVolume:
17
Language:
english
Journal:
Journal of the International AIDS Society
DOI:
10.7448/ias.17.4.19532
Date:
November, 2014
File:
PDF, 84 KB
english, 2014